Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Leukemia Research
|
February 15, 2011
Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study
Fermin M Sánchez-Guijo, Soledad Durán, Josefina Galende, et al.
Spinal Cord
|
June 19, 2024
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury
Pablo V Escribá, Ángel M Gil-Agudo, Joan Vidal Samsó, et al.
Blood Advances
|
July 22, 2018
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms
Carolina Martínez-Laperche, Elena Buces, M Carmen Aguilera-Morillo, et al.
Plos One
|
October 17, 2015
The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation
Víctor Noriega, Carolina Martínez-Laperche, Elena Buces, et al.
Nature Ecology & Evolution
|
February 20, 2026
Author Correction: Tree diversity is changing across tropical Andean and Amazonian forests in response to global change
B Fadrique, F Costa, F Cuesta, et al.
Nature Ecology & Evolution
|
January 23, 2026
Tree diversity is changing across tropical Andean and Amazonian forests in response to global change
B Fadrique, F Costa, F Cuesta, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Leukemia Research
|
February 15, 2011
Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study
Fermin M Sánchez-Guijo, Soledad Durán, Josefina Galende, et al.
Spinal Cord
|
June 19, 2024
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury
Pablo V Escribá, Ángel M Gil-Agudo, Joan Vidal Samsó, et al.
Blood Advances
|
July 22, 2018
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms
Carolina Martínez-Laperche, Elena Buces, M Carmen Aguilera-Morillo, et al.
Plos One
|
October 17, 2015
The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation
Víctor Noriega, Carolina Martínez-Laperche, Elena Buces, et al.
Nature Ecology & Evolution
|
February 20, 2026
Author Correction: Tree diversity is changing across tropical Andean and Amazonian forests in response to global change
B Fadrique, F Costa, F Cuesta, et al.
Nature Ecology & Evolution
|
January 23, 2026
Tree diversity is changing across tropical Andean and Amazonian forests in response to global change
B Fadrique, F Costa, F Cuesta, et al.
Page
of 6